UroGen Pharma Ltd. stock is up 15.92% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 6 March’s closed higher than February. In the last 1 Unusual Options Trades, there were 1 CALL.
UroGen Pharma Ltd. engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs. The company's lead product candidate is UGN-102, which is in Phase III clinical trials.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!